E-LIB Suche - Ergebnisse für: Elbedewy, Tamer A.

1

Forgotten Biliary Plastic Stents: Complications, Management..:

Elsebaey, Mohamed A. ; Enaba, Mohamed Elsayed ; Elashry, Heba...
Medicina. 60 (2024) 8 - p. 1258 , 2024

Link: https://doi.org/10.3390/..

2

Resolved hepatitis B infection in patients receiving immuno..:

Elsebaey, Mohamed A. ; Elbedewy, Tamer A. ; Elashry, Heba...
Medicine. 101 (2022) 47 - p. e31962 , 2022

Link: https://doi.org/10.1097/..

3

Retrospective study of Dana Farber Consortium Protocol in n..:

Elashtokhy, Hossam Eldin A. ; Elgohary, Heba E. ; Eldeep, Basant B...
Journal of the Egyptian National Cancer Institute. 33 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

4

Intermittent versus Daily Eltrombopag Dosage Protocols for ..:

Elbedewy, Tamer ; Elsebaey, Mohamed A ; Elkholy, Reem A..
Journal of Blood Medicine. 11 (2020) - p. 533-542 , 2020

Link: https://doi.org/10.2147/..

5

Impact of CD40 gene polymorphisms on the risk of immune thr..:

AbdelGhafar, Muhammad Tarek ; El-Kholy, Rasha A. ; Elbedewy, Tamer A....
Gene. 736 (2020) - p. 144419 , 2020

Link: https://doi.org/10.1016/..

6

EFFECT OF FENOFIBRATE ADJUVANT THERAPY ON ENDOTHELIAL DYSFU..:

K HEGAZY, SAHAR ; A ELBEDEWY, TAMER ; M SAMI, HAIDY
Asian Journal of Pharmaceutical and Clinical Research. , 2020

Link: https://doi.org/10.22159..

7

Comparative study to evaluate the effect of l-carnitine plu..:

El-sheikh, Hadier M. ; El-Haggar, Sahar M. ; Elbedewy, Tamer A.
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 13 (2019) 1 - p. 167-173 , 2019

Link: https://doi.org/10.1016/..

8

Predictors for eltrombopag response in patients with hepati..:

Elbedewy, Tamer A ; Elsebaey, Mohamed A ; Elshweikh, Samah A..
Therapeutics and Clinical Risk Management. 15 (2019) - p. 269-274 , 2019

Link: https://doi.org/10.2147/..

9

Prevalence and chemotherapy-induced reactivation of occult ..:

Elbedewy, Tamer A. ; Elashtokhy, Hossam Eldin A. ; Rabee, Enaam S..
Journal of the Egyptian National Cancer Institute. 27 (2015) 1 - p. 11-18 , 2015

Link: https://doi.org/10.1016/..

10

Prevalence of metabolic syndrome in beta-thalassemia major ..:

Eida, Reham Abd Elmageed Abo ; Elbedewy, Tamer Abd Elhamid ; Mabrouk, Maaly Mohamed.
International journal of health sciences. , 2022

Link: https://doi.org/10.53730..

11

Prevalence of metabolic syndrome in beta-thalassemia major ..:

Eida, Reham Abd Elmageed Abo ; Elbedewy, Tamer Abd Elhamid ; Mabrouk, Maaly Mohamed.
International journal of health sciences. , 2022

Link: https://doi.org/10.53730..

12

Resolved hepatitis B infection in patients receiving immuno..:

Elsebaey, Mohamed A ; Elbedewy, Tamer A ; Elashry, Heba...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704936/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Intermittent versus Daily Eltrombopag Dosage Protocols for ..:

Elbedewy, Tamer ; Elsebaey, Mohamed A ; Elkholy, Reem A..
info:eu-repo/semantics/altIdentifier/doi/10.2147/JBM.S289149. , 2020

Link: https://www.dovepress.co..

14

Intermittent versus Daily Eltrombopag Dosage Protocols for ..:

Elbedewy, Tamer A ; Elsebaey, Mohamed A ; Elkholy, Reem A..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783199/. , 2020

Link: http://www.ncbi.nlm.nih...

15

Predictors for eltrombopag response in patients with hepati..:

Elbedewy, Tamer A ; Elsebaey, Mohamed A ; Elshweikh, Samah A..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375108/. , 2019

Link: http://www.ncbi.nlm.nih...